Viking Therapeutics
VKTX
#3883
Rank
ยฃ2.54 B
Marketcap
ยฃ19.93
Share price
-2.64%
Change (1 day)
-30.60%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2026 (TTM): -ยฃ0.48 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ0.28 Billion a decrease over its 2024 earnings that were of -ยฃ83.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.48 Billion72.07%
2025 -ยฃ0.28 Billion227.05%
2024 -ยฃ83.76 Million28.02%
2023 -ยฃ65.43 Million24.73%
2022 -ยฃ52.46 Million25.24%
2021 -ยฃ41.89 Million39.23%
2020 -ยฃ30.09 Million53.21%
2019 -ยฃ19.64 Million16.84%
2018 -ยฃ16.81 Million7.22%
2017 -ยฃ15.68 Million39.68%
2016 -ยฃ11.23 Million-37.05%
2015 -ยฃ17.83 Million6.94%
2014 -ยฃ16.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-ยฃ0.35 Billion-28.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ23.36 M-104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ2.86 M-100.60%๐Ÿ‡บ๐Ÿ‡ธ USA